According to a recently published Future Market Insights study, the endometrial ablation market sales is predicted to reach US$ 3.4 billion in sales in 2023 and rise at a compound annual growth rate (CAGR) of 7.3% between 2023 and 2033. By the end of 2033, it is projected that the market will reach US$ 6.8 billion. The total GDP of the US and China in 2022 was US$ 1.4 billion.
Endometrial ablation is a medical procedure designed to treat abnormal uterine bleeding by removing or destroying the lining of the uterus, known as the endometrium. This technique is often considered for women who experience heavy menstrual bleeding (menorrhagia) that doesn’t respond well to other treatments like medications. By targeting the endometrial lining, the procedure aims to reduce or eliminate menstrual bleeding, offering relief to those who suffer from this debilitating condition.
Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-16577
The endometrial ablation procedure is minimally invasive, and it is usually performed on an outpatient basis. It offers several advantages compared to more invasive surgical options like hysterectomy. Some benefits of endometrial ablation include shorter recovery times, lower risks of complications, and the preservation of the uterus. This is particularly important for women who still wish to have children in the future.
With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.
The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by ABillionormal Uterine Bleeding. Women’s treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women’s health at the center of their wellbeing race.
In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women’s healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.
Key players:
- Medtronic
- CooperSurgical Inc.
- Boston Scientific Corp.
- Ethicon, Inc.
- Olympus Corp.
- Richard Wolf GmbH
- AngioDynamics
- Hologic, Inc.
- Minerva Surgical, Inc.
Elevate Strategy: Tap into Analyst Expertise Now:
https://www.futuremarketinsights.com/ask-question/rep-gb-16577
A few of the recent developments in the market are:
- In February 2021, CooperSurgical, a division of CooperCompanies, acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
- In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
- In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division’s worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
- In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific’s electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company’s offerings.
Key Segments:
By Type:
- Devices
- Cryoablation
- Radiofrequency Ablation
- Hydrothermal Ablation
- Thermal Balloon
- Microwave Energy
- Procedures
By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
Unleash Potential: Craft Your Customized Report Now :
https://www.futuremarketinsights.com/customization-available/rep-gb-16577
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube